Scleroderma, Systemic Recruiting Phase 1 Trials for Nintedanib (DB09079)

Also known as: Systemic Scleroderma

IndicationStatusPhase
DBCOND0028174 (Scleroderma, Systemic)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs